Sangamo Therapeutics, Inc. , a genomic medicine company, today announced that the American Society of Gene & Cell Therapy (ASGCT) has accepted nine Sangamo abstracts for presentation at the 28th ASGCT ...

Mirum Pharmaceuticals, Inc. today announced that it will present data at three upcoming medical congresses. Digestive Disease Week (DDW) will be held in San Diego, May 3-6, 2025. The European ...

The Texas A&M Department of Engineering held its annual project showcase Friday with 1,773 senior students participating.

An investment forum during the 15th Beijing International Film Festival brought together executives from the likes of Bona ...

Plan now to have your poster included in the 2026 Cell & Gene Therapy Virtual Event Series. Submission is free. Submit your abstract here. Our virtual conference allows you to participate in a global ...

Political posters and signs proliferate at election time. Why do candidates risk the wrath of voters with what many regard as ...

announces it will be presenting a poster at the American Society of Clinical Oncology (ASCO) 2025 Annual Meeting to be held May 30-June 3, 2025 at McCormick Place, Chicago, Ill. The poster is ...

WASHINGTON — The White House on Monday opened a weeklong celebration of Donald Trump’s first 100 days in office by focusing on his border crackdown, an area of relative strength for the president at a ...

"We are excited to build on our recent momentum of achieving full enrollment in our Phase 3 PROTECT study with a poster presentation at SCA 2025 that we can share with the global anesthesiologist ...

today announced a poster presentation at the upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting to be held online and at the McCormick Place Convention Center in Chicago ...

BioAtla is a global clinical-stage biotechnology company with operations in San Diego, California, and in Beijing, China through its contractual relationship with BioDuro-Sundia, a provider of ...

Data on the neoadjuvant ONO-4578 (EP4 antagonist) in combination with nivolumab for rectal cancer will be presented in a poster session. "We are fully committed to developing innovative drugs for ...